Comprehensive Artificial Intelligence In Oncology Market Forecast 2025-2034: Growth Trends and Strategic Shifts

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Artificial Intelligence In Oncology Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The overall valuation of the artificial intelligence sector within oncology has experienced rapid and substantial expansion recently, projected to increase from $1.78 billion in the year 2024 to $2.35 billion in 2025, reflecting a compound annual growth rate of 31.5 percent; this upward trend during the historical period is fundamentally linked to several key factors, including the increasing frequency of cancer diagnoses, the vast amounts of health data becoming available, enhancements in clinical trial processes, the growing requirement for tailored patient treatments, and improved operational performance within both radiology and pathology specializations.

Artificial Intelligence In Oncology Market Size Forecast: What's the Projected Valuation by 2029?
Forecasting robust expansion, the market dedicated to artificial intelligence within oncology is projected to experience a rapid surge over the upcoming years, reaching a valuation of $7.55 billion by 2029, fueled by a compound annual growth rate (CAGR) calculated at 34.0%. This accelerated trajectory throughout the projection timeframe stems from developments such as the incorporation of AI alongside electronic health records (EHR), wider deployment in aiding treatment choices, enhancing patient involvement and informational resources, favorable regulatory backing, and systematic standardization efforts. Key shifts shaping this period involve the increasing adoption of natural language processing (NLP) technologies in medical settings, leveraging AI for identifying new biomarkers, emphasizing transparent and understandable AI systems to foster clinical acceptance, embedding AI into managing overall population health, forging partnerships between AI innovators and healthcare delivery organizations, and continuous refinement of predictive analytical capabilities.

View the full report here:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-oncology-global-market-report

What Are the Drivers Transforming the Artificial Intelligence In Oncology Market?
Anticipated increases in cancer occurrences globally are projected to fuel the expansion of the AI in oncology sector in the future. Given that cancer involves a complicated set of conditions involving the unrestrained multiplication and spreading of atypical cells within an organism, bringing artificial intelligence into oncology promises to transform cancer treatment, facilitating greater accuracy, tailored methodologies, and streamlined processes. As an illustration, data released in 2023 by the American Cancer Society Inc., a non-profit health entity located in the United States, indicated an escalation in the projected count of new cancer diagnoses, moving from 1.8 million to 1.9 million; consequently, this upward trend in cancer rates serves as a primary catalyst for the market growth in AI applications for oncology.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13130&type=smp

What Long-Term Trends Will Define the Future of the Artificial Intelligence In Oncology Market?
Key players within the AI in oncology sector are concentrating efforts on pioneering new software, specifically those built on cloud infrastructure, aiming to boost effectiveness and deliver superior offerings.Cloud technology is instrumental in AI utilization for oncology, furnishing a readily available, adaptable, and scalable environment fit for handling and scrutinizing expansive datasets in the medical field.As an illustration, during March of 2023, the American biotechnology firm Illumina Inc. introduced Connected Insights, novel cloud-based software engineered to facilitate tertiary analysis specifically for oncology use cases.This Connected Insights software, by incorporating external data repositories, simplifies how results from diverse assay methodologies are understood and documented, empowering laboratories to broaden their application of NGS technology and accelerate the completion timeline for clinical documentation.

Which Segments in the Artificial Intelligence In Oncology Market Offer the Most Profit Potential?
The artificial intelligence in oncologymarket covered in this report is segmented -

1) By Component: Software Solutions; Hardware; Services
2) By Treatment Type: Chemotherapy; Radiotherapy; Immunotherapy; Other Treatment Types
3) By Cancer Type: Breast Cancer; Lung Cancer; Prostate Cancer; Colorectal Cancer; Brain Tumor; Other Cancer Types
4) By Application: Cancer Detection; Drug Discovery; Drug Development; Other Applications
5) By End-Users: Hospitals; Diagnostic Centers; Pharmaceutical Companies; Research Institutes; Other End Users

Subsegments:
1) By Software Solutions: Diagnostic Software; Treatment Planning Software; Patient Management Software; Data Analytics Platforms
2) By Hardware: AI-Enabled Imaging Devices; High-Performance Computing Systems; Wearable Health Monitors
3) By Services: Consulting Services; Integration Services; Maintenance And Support Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13130&type=smp

Which Firms Dominate the Artificial Intelligence In Oncology Market by Market Share and Revenue in 2025?
Major companies operating in the artificial intelligence in oncology market report are Azra AI, IBM Corporation, Siemens Healthcare GmbH, Intel Corporation, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI Inc., PathAI Inc., Median Technologies SA, Kheiron Medical Technologies Ltd., Hampton Research Inc., Tempus Labs Inc., Paige AI Inc., Prognos Health Inc., Enlitic, Inspirata Inc., Berg LLC, Proscia Inc., Prognos Health Inc., Deep 6 AI Inc., Ibex Medical Analytics, Nanox Imaging Ltd., Zebra Medical Vision, Globavir Biosciences Inc.

Which Regions Offer the Highest Growth Potential in the Artificial Intelligence In Oncology Market?
North America was the largest region in the AI in oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13130

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.